MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chimerix, Inc. - Common Stock (NQ:CMRX)

8.540 UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.540
Bid (Size) 8.540 (92)
Ask (Size) 8.550 (1)
Prev. Close 8.540
Today's Range 8.540 - 8.540
52wk Range 0.8000 - 8.550
Shares Outstanding 93,803,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology
Via Investor Brand Network
Topics Artificial Intelligence
Top 3 Health Care Stocks That May Crash In Q2
 
Via Benzinga

Performance

YTD
+151.9%
+151.9%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+0.5%
+0.5%
1 Year
+910.8%
+910.8%

More News

Read More
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
From Chimerix, Inc.
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDFN, BLBX, CMRX, WBA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
This MongoDB Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Via Benzinga
Demystifying Chimerix: Insights From 4 Analyst Reviews
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq – TURN)
From Brodsky & Smith LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VOXX, CMRX, WBA, ML on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
CMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume stocks are being observed in Thursday's session.
Via Chartmill
Here are the top movers in Wednesday's session.
Via Chartmill
These stocks are making the most noise in today's session.
Via Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, IVAC, BRDG on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Chimerix, Inc. (Nasdaq - CMRX), Siyata Mobile Inc. (Nasdaq - SYTA), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Intevac, Inc. (Nasdaq - IVAC)
From Brodsky & Smith LLC
Via GlobeNewswire
Wednesday's session: gap up and gap down stocks
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
Via Benzinga
CMRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chimerix, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
From Chimerix, Inc.; Jazz Pharmaceuticals plc
Via GlobeNewswire
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
From Chimerix, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Chimerix, Inc. - Common Stock publicly traded?
Yes, Chimerix, Inc. - Common Stock is publicly traded.
What exchange does Chimerix, Inc. - Common Stock trade on?
Chimerix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Chimerix, Inc. - Common Stock?
The ticker symbol for Chimerix, Inc. - Common Stock is CMRX on the Nasdaq Stock Market
What is the current price of Chimerix, Inc. - Common Stock?
The current price of Chimerix, Inc. - Common Stock is 8.540
When was Chimerix, Inc. - Common Stock last traded?
The last trade of Chimerix, Inc. - Common Stock was at 04/17/25 04:00 PM ET
What is the market capitalization of Chimerix, Inc. - Common Stock?
The market capitalization of Chimerix, Inc. - Common Stock is 801.08M
How many shares of Chimerix, Inc. - Common Stock are outstanding?
Chimerix, Inc. - Common Stock has 801M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story